comparemela.com

Latest Breaking News On - Shantanu nigam - Page 2 : comparemela.com

SeedtoB Capital Invests in Innovative Epigenetics Startup Epinoma

Atlanta, GA (PRWEB) October 21, 2021 SeedtoB Capital, an Atlanta-based venture fund focused on healthcare innovation, announced today that it has invested

Germany
Shantanu-nigam
Pritesh-sharma
George-church
Varun-govil
San-carlos
Seedtob-capital
Tob-capital
Press-release

SeedtoB Capital Invests in Innovative Allergy Treatment Startup Moonlight Therapeutics

SeedtoB Capital Invests in Innovative Allergy Treatment Startup Moonlight Therapeutics
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.

United-states
Georgia
Texas
Atlanta
Shantanu-nigam
Samir-patel
Pritesh-sharma
Moonlight-therapeutics-inc
National-institutes-of-health
National-institute-of-allergy
Texas-tech-university
Georgia-research-alliance

Shantanu Nigam joins Damo Consulting Board of Advisors

Shantanu Nigam joins Damo Consulting Board of Advisors Share Article CHICAGO (PRWEB) February 16, 2021 Damo Consulting, a leading digital strategy consultancy for healthcare enterprises and technology firms, today announced the addition of Shantanu Nigam as the Advisory Board member. Shantanu Nigam is the Managing Partner of SeedToB, a venture capital and private equity firm focused on healthcare AI startups. Previously, he was the Co-Founder and CEO of Jvion, a leading healthcare AI company that offers a range of clinical AI applications that prevent avoidable harm, optimize utilization and improve health outcomes. Jvion was rated by KLAS as the #1 Clinical AI company in the country both in terms of number of clients served as well as revenue.

Shantanu-nigam
Advisory-board
Managing-partner
Damo-consulting
Board-advisor
Paddy-padmanabhan
Healthcare-digital-transformation
Press-release
சாந்தனு-நீகம்
நிர்வகித்தல்-கூட்டாளர்
டாமோ-ஆலோசனை

Fast-Growing Oncology Startup OncoLens Secures $7.25 Million Series A Funding

Share this article Share this article ATLANTA, Jan. 13, 2021 /PRNewswire/  OncoLens, a pioneer in tumor board and cancer treatment planning solutions, announced today that it has raised a $7.25 million Series A investment from BIP Capital, Martin Ventures, and SeedToB Capital, a new healthcare artificial intelligence (AI) venture fund launched by former Jvion Co-founders Shantanu Nigam and Ritesh Sharma. OncoLens brings collaborative and personalized treatment planning to the cancer patient through data integration and decision support. It helps cancer programs and their multidisciplinary teams of specialists collaborate effectively while easily aggregating patient-specific data in a HIPAA-compliant manner across different EMR/clinical/genetics information systems. Patient-specific clinical trials at a facility or its affiliates, NCCN/ASCO guidelines, and the latest research are also automatically identified for each case to support the care team in making the best decision f

Georgia
United-states
Tennessee
Atlanta
American
Kathy-berardi
Shantanu-nigam
Pritesh-sharma
Charlie-martin
Anju-mathew
Mark-buffington
Devin-carty

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.